P Tsirigotis
Overview
Explore the profile of P Tsirigotis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neroutsos E, Athanasiadou I, Paisiou A, Zisaki K, Goussetis E, Archontaki H, et al.
J Pharm Pharmacol
. 2021 Jul;
73(10):1340-1350.
PMID: 34244783
Objectives: To apply therapeutic drug monitoring and dose-individualization of intravenous Busulfan to paediatric patients and evaluate the impact of syringe-pump induced Busulfan infusion lag-time after in vitro estimation. Methods: 76...
2.
Tsirigotis P, Liga M, Gkirkas K, Stamouli M, Triantafyllou E, Marangos M, et al.
Bone Marrow Transplant
. 2016 Dec;
52(3):445-451.
PMID: 27941776
We analyzed the use of low-dose alemtuzumab in a cohort of 158 consecutive patients who underwent allogeneic PBSC transplantation. Patients with high-risk acute leukemia were prospectively screened for prophylactic donor...
3.
Tsirigotis P, Byrne M, Schmid C, Baron F, Ciceri F, Esteve J, et al.
Bone Marrow Transplant
. 2016 Jun;
51(11):1431-1438.
PMID: 27295272
Allogeneic hematopoietic stem cell transplantation (allo-SCT) remains the therapeutic method with the most potent anti-leukemic activity mediated by the graft versus leukemia effect. However, a significant proportion of patients with...
4.
Kousoulakou H, Symeonidis A, Kyriakou D, Sotiropoulos D, Gigantes S, Delimbasi S, et al.
Value Health
. 2016 May;
17(7):A528.
PMID: 27201672
No abstract available.
5.
Tsirigotis P, Danylesko I, Gkirkas K, Shem-Tov N, Yerushalmi R, Stamouli M, et al.
Bone Marrow Transplant
. 2016 May;
51(10):1313-1317.
PMID: 27183095
In our study, we evaluated the safety and efficacy of Brentuximab vedotin (BV) with or without the addition of donor lymphocyte infusion (DLI) after allogeneic stem cell transplantation (allo-SCT) in...
6.
Tsirigotis P, Papanikolaou N, Elefanti A, Konstantinou P, Gkirkas K, Rontogianni D, et al.
Antimicrob Agents Chemother
. 2015 Sep;
59(12):7367-73.
PMID: 26369979
Janus kinases (JAK) are intracellular tyrosine kinases that transduce cytokine-mediated signals to the nucleus, promoting gene expression. Cytokines play a major role in microbial sepsis, which is often associated with...
7.
Kelaidi C, Tzannou I, Baltadakis I, Batsis I, Mallouri D, Spyridonidis A, et al.
Bone Marrow Transplant
. 2014 May;
49(8):1022-8.
PMID: 24797183
Newer cytogenetic scoring systems for myelodysplastic syndromes (MDSs), like cytogenetic stratification of the revised international prognostic scoring system (IPSS-R) or monosomal karyotype, may also improve outcome prediction after hematopoietic SCT...
8.
Zygogianni A, Kyrgias G, Psyrri A, Kantzou I, Koumarianou A, Tolia M, et al.
J BUON
. 2012 Apr;
17(1):116-23.
PMID: 22517704
The treatment of Hodgkin's lymphoma (HL) is associated with significant toxicity. The objective of high quality management is to keep the concept of combined modality, while trying to decrease the...
9.
Tsirigotis P, Shapira M, Or R, Bitan M, Samuel S, Gesundheit B, et al.
Bone Marrow Transplant
. 2009 Dec;
45(7):1189-96.
PMID: 19946341
The influence of graft composition on the outcome of reduced-intensity (RIC) allogeneic PBSC transplantation (allo-PBSC) remains controversial. In this study, we analyzed the impact of CD34+ cell dose on the...
10.
Shapira M, Abdul-Hai A, Resnick I, Bitan M, Tsirigotis P, Aker M, et al.
Bone Marrow Transplant
. 2008 Oct;
43(4):339-43.
PMID: 18850020
Alefacept (Amevive) is an immunosuppressive dimeric fusion protein that is used for psoriasis control. We recently showed its effect in acute steroid-resistant/dependent GVHD. In this study, we describe the effect...